CN109503579A - The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester - Google Patents

The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester Download PDF

Info

Publication number
CN109503579A
CN109503579A CN201811539869.8A CN201811539869A CN109503579A CN 109503579 A CN109503579 A CN 109503579A CN 201811539869 A CN201811539869 A CN 201811539869A CN 109503579 A CN109503579 A CN 109503579A
Authority
CN
China
Prior art keywords
reaction
added
thriazaspiro
butyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811539869.8A
Other languages
Chinese (zh)
Inventor
蒋欣欣
周强
任文武
李红
何米娜
李庆攀
吴东平
何华敬
安自强
刘月领
吴艳
何燕平
焦家盛
于凌波
马汝建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi Apptec Tianjin Co Ltd
Original Assignee
Wuxi Apptec Tianjin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Apptec Tianjin Co Ltd filed Critical Wuxi Apptec Tianjin Co Ltd
Priority to CN201811539869.8A priority Critical patent/CN109503579A/en
Publication of CN109503579A publication Critical patent/CN109503579A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to a kind of tert-butyl -1- methyl -5- oxygen subunit-Isosorbide-5-Nitrae, the preparation methods of 9- thriazaspiro [5.5] hendecane -9- formic acid base ester, the technical issues of mainly solution currently without suitable Industrialized synthesis method.The present invention is total in two steps: the first step, ethylenediamine and benzyltriethylammoinium chloride are added in methylene chloride;5-20 DEG C is added drop-wise to sodium hydrate aqueous solution in reaction solution;It is stirred to react, N- tertbutyloxycarbonyl -4- piperidones is then dissolved in the mixture that chlorination is imitative after methylene chloride and is added drop-wise in above-mentioned reaction solution, reaction obtains compound 2;Compound 2 is dissolved in methanol by second step, and formalin and acetic acid is added;Sodium cyanoborohydride is added at 0 DEG C;Mixture is stirred to react, and reaction terminates, and processing purifying obtains final product.The compound that the present invention obtains provides useful intermediate or product for the synthesis of many drugs.

Description

Tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester Preparation method
Technical field
The present invention relates to tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester, i.e., tertiary fourths Base -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro [5.5] hendecane -9- formic acid base ester (CAS:1263177-81-6) Preparation method.
Background technique
Tert-butyl -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro [5.5] hendecane -9- formic acid base ester and relevant spread out Biology has in pharmaceutical chemistry and organic synthesis to be widely applied.At present about tert-butyl -1- methyl -5- oxygen subunit -1,4,9- Seldom, there are certain risk and roads for similar document reaction for the synthesis report of thriazaspiro [5.5] hendecane -9- formic acid base ester Wire length, yield are lower.Therefore it needs to develop a raw material to be easy to get, it is easy to operate, react easily controllable, the suitable conjunction of overall yield At method.
Summary of the invention
It is easy to operate the purpose of the present invention is developing one kind to be easy to get with raw material, react easily controllable, the higher uncle of yield The preparation method of butyl -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro [5.5] hendecane -9- formic acid base ester.Mainly solve The technical issues of currently without suitable Industrialized synthesis method.
A kind of technical solution of the present invention: tert-butyl -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro [5.5] 11 The preparation method of alkane -9- formic acid base ester, includes the following steps, the present invention in two steps, the first step, ethylenediamine and benzyl triethyl ammonium chlorine Change ammonium to be added in methylene chloride;5-20 DEG C is added drop-wise to sodium hydrate aqueous solution in reaction solution;It is stirred to react, then by the tertiary fourth of N- Oxygen carbonyl -4- piperidones is dissolved in the mixture that chlorination is imitative after methylene chloride and is added drop-wise in above-mentioned reaction solution, and reaction obtains compound 2.Compound 2 is dissolved in methanol by second step, and formalin and acetic acid is added;Sodium cyanoborohydride is added at 0 DEG C;Mixing Object is stirred to react, and reaction terminates, and processing purifying obtains compound 3.Reaction equation is as follows:
For first step reaction temperature practical range at 5-25 DEG C, the reaction time is 8 hours;Second step reaction temperature practical range is in 0- 25 DEG C, the reaction time 16 hours.
Beneficial effects of the present invention: the present invention provides a kind of synthesizing tertiary butyl -1- methyl -5- oxygen subunit -1,4,9- three The method of azaspiro [5.5] hendecane -9- formic acid base ester, this method synthetic route is short, and yield may be up to 70%, and reaction is easy to put Greatly, easy to operate, there is industrial applications prospect.
Specific embodiment
Reaction equation of the present invention is as follows:
Embodiment 1:a, ethylenediamine (18.10 g, 301.13 mmol, 20.15 mL, 1.2eq) and benzyl triethyl ammonium chlorination Ammonium (2.86 g, 12.55 mmol, 0.05eq) be added in DCM (200 mL);Reaction cools to 5 degrees centigrades;It will Sodium hydroxide (100.38 g, 2.51 mol, 10eq) aqueous solution that is dissolved in water (150 mL) is added drop-wise in reaction solution;Charging Temperature maintains 5-20 degrees Celsius in the process, drips reaction and stirs 2 hours, N- tertbutyloxycarbonyl -4- piperidones (50 g, 250.95 mmol, 1 eq) be dissolved in methylene chloride (200 mL) afterwards chlorination it is imitative (44.94 g, 376.42 mmol, 30.36 mL, 1.5 eq) mixture be added drop-wise in the reaction solution of front, mixture stirs 6 hours under 25 degrees Celsius.TLC (dichloro Methane/methanol volume ratio=20/1) display reaction terminates, with water (500 mL) quenching reaction, reaction solution saline solution later It washes, water phase is extracted with dichloromethane, and merges organic phase and is dried over sodium sulfate, filters and be evaporated under reduced pressure, column chromatographic purifying obtains Huang The compound 2 (40 g, crude) of color solid, yield 70%.
B, by compound 2(tert-butyl -5- oxygen subunit -1,4,9- thriazaspiro [5.5] hendecane -9- formic acid base ester) (10 g, 37.13 mmol, 1 eq) be dissolved in methanol (100 mL), 20 degrees Celsius of addition formalins (30.13 g, 371.28 mmol, 27.65 mL, 37% purity, 10 eq) and acetic acid (22.30 g, 371.28 mmol, 21.23 mL, 10eq);Reaction under 0 degree Celsius be added sodium cyanoborohydride (4.67 g, 74.26 mmol, 2eq);Mixture is Celsius 25 Degree lower stirring 16 hours, TLC (methylene chloride/methanol volume ratio=20/1) display reaction terminated, and reaction solution vacuum distillation is residual Slag is extracted with ethyl acetate after being dissolved in water, and organic phase is washed with salt later, merges organic phase and is dried over sodium sulfate, filters and subtract Pressure distillation, column chromatographic purifying obtain the compound 3 (8 g, crude) of yellow solid, yield 70%.
1H NMR (400MHz, CHLOROFORM-d) δ = 6.52 (br s, 1H), 3.92 (br s, 1H), 3.86 (br s, 1H), 3.34 (dt, J=2.4, 5.4 Hz, 2H), 3.09 (br s, 1H), 3.02 (br t, J =5.3 Hz, 2H), 2.86 (br s, 1H), 2.49 (s, 3H), 2.10 (dt,J=4.8, 12.9 Hz, 2H), 1.57 (br s, 1H), 1.44 (s, 9H), 1.30 - 1.23 (m, 1H)。

Claims (3)

1. a kind of preparation side of tert-butyl -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro [5.5] hendecane -9- formic acid base ester Method, it is characterized in that: the following steps are included: the first step, ethylenediamine and benzyltriethylammoinium chloride are added in methylene chloride;5-20℃ Sodium hydrate aqueous solution is added drop-wise in reaction solution;It is stirred to react, N- tertbutyloxycarbonyl -4- piperidones is then dissolved in dichloromethane The imitative mixture of chlorination is added drop-wise in above-mentioned reaction solution after alkane, and reaction obtains compound 2;Compound 2 is dissolved in methanol by second step In, formalin and acetic acid is added;Sodium cyanoborohydride is added at 0 DEG C;Mixture is stirred to react, and reaction terminates, and is handled pure Change obtains compound 3;Reaction equation is as follows:
2. a kind of tert-butyl -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro according to claim 1 [5.5] 11 The preparation method of alkane -9- formic acid base ester, it is characterized in that: first step reaction temperature practical range at 5-25 DEG C, reacts 8 hours.
3. a kind of tert-butyl -1- methyl -5- oxygen subunit -1,4,9- thriazaspiro according to claim 1 [5.5] 11 The preparation method of alkane -9- formic acid base ester, it is characterized in that: second step reaction temperature practical range is at 0-25 DEG C, the reaction time 16 is small When.
CN201811539869.8A 2018-12-17 2018-12-17 The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester Pending CN109503579A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811539869.8A CN109503579A (en) 2018-12-17 2018-12-17 The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811539869.8A CN109503579A (en) 2018-12-17 2018-12-17 The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester

Publications (1)

Publication Number Publication Date
CN109503579A true CN109503579A (en) 2019-03-22

Family

ID=65752647

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811539869.8A Pending CN109503579A (en) 2018-12-17 2018-12-17 The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester

Country Status (1)

Country Link
CN (1) CN109503579A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103608336A (en) * 2011-02-01 2014-02-26 勃林格殷格翰国际有限公司 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
CN106892928A (en) * 2017-02-07 2017-06-27 上海药明康德新药开发有限公司 A kind of synthetic method of the carboxylate of 8 hydroxyl of the tert-butyl group, 5 oxa- 2 azaspiro [3.5] nonane 2
CN107216335A (en) * 2017-06-29 2017-09-29 上海药明康德新药开发有限公司 The formic acid base ester preparation method of 3 oxa- of a kind of tert-butyl group 1 (methylol) 9 azaspiro [5.5] hendecane 9
CN108863958A (en) * 2018-07-20 2018-11-23 南京药石科技股份有限公司 A kind of preparation method of 4,7- diaza spiro [2.5] Octane derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103608336A (en) * 2011-02-01 2014-02-26 勃林格殷格翰国际有限公司 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
CN106892928A (en) * 2017-02-07 2017-06-27 上海药明康德新药开发有限公司 A kind of synthetic method of the carboxylate of 8 hydroxyl of the tert-butyl group, 5 oxa- 2 azaspiro [3.5] nonane 2
CN107216335A (en) * 2017-06-29 2017-09-29 上海药明康德新药开发有限公司 The formic acid base ester preparation method of 3 oxa- of a kind of tert-butyl group 1 (methylol) 9 azaspiro [5.5] hendecane 9
CN108863958A (en) * 2018-07-20 2018-11-23 南京药石科技股份有限公司 A kind of preparation method of 4,7- diaza spiro [2.5] Octane derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BELL: "[11C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor", 《ACS MEDICINAL CHEMISTRY LETTERS》 *
RN:1263177-81-6: "Chemical Abstract Service", 《STNEXT REGISTRY 数据库》 *

Similar Documents

Publication Publication Date Title
JP7269270B2 (en) Method for producing sugammadex and intermediates thereof
US20080154045A1 (en) Process for Producing 1-Substituted-3-Fluoroalkylpyrazole-4-Carboxylate
CN103265420B (en) A kind of preparation method of aromatic diketone compound
CN104402909A (en) Synthetic method of cefoxitin acid
CN109384827A (en) A kind of budesonide industrialized process for preparing
CN106892928B (en) A kind of synthetic method of tertiary butyl -8- hydroxyls -5- oxa- -2- azaspiros [3.5] nonane -2- carboxylates
TWI540119B (en) Compound, method for producing the same, and method for producing oseltamivir phosphate
CN103130708B (en) A kind of preparation method of N-tertbutyloxycarbonyl-4-nitro piperidines
CN109503579A (en) The preparation method of tert-butyl -1- methyl -5- oxygen subunit thriazaspiro [5.5] hendecane -9- formic acid base ester
CN112812059A (en) Preparation method of 2-aminosulfonyl-N, N-dimethylnicotinamide
CN107216332B (en) The synthetic method of 5 (6H) formic acid base ester of tert-butyl -7- methylol -7,8- dihydro 4H pyrazolo diazepine
JP6676146B2 (en) Novel production method of chromanol derivative
CN109608460A (en) A kind of synthetic method of 1,10- dioxy subunit -2,7- diaza spiro [4.5] decane -7- t-butyl formate
CN104402813B (en) Novel method for synthesizing sorafenib
CN108546266B (en) Synthesis method of 1,4,6, 7-tetrahydropyrane [4,3-C ] pyrazole-3-carboxylic acid
JP5501054B2 (en) Method for producing 3,3-diaminoacrylic acid (1-diphenylmethylazetidin-3-yl) ester acetate
JP2018039773A (en) Nitrogen-containing nine-membered cycloalkyne
UA114158C2 (en) A method for preparing an intermediate of iopromide
CN111138354A (en) Preparation method of isoniazid
CN105601639B (en) A kind of 6- tertbutyloxycarbonyls octahydro -2H- pyrans [3,2-c] and the synthetic method of pyridine -8- carboxylic acids
CN103992257B (en) A kind of purification process of Vildagliptin crude product
CN105017268A (en) 2-tertbutyloxycarbonyl-7-carbonyl-5-O-2-azaspiro(3.4)octane synthesis method
CN111574448B (en) Preparation method of phenyl tetrahydroisoquinoline
CN107235975B (en) The synthetic method of tert-butyl 6- benzyl -4- oxygen subunit octahydro -1H- pyrrolo- [3,4-b] picolinic acid ester
CN110418797B (en) Method for preparing ketolide compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190322

WD01 Invention patent application deemed withdrawn after publication